Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry

Gian Paolo Ussia, Marco Barbanti, Antonio Colombo, Giuseppe Tarantini, Anna Sonia Petronio, Federica Ettori, Angelo Ramondo, Gennaro Santoro, Silvio Klugmann, Francesco Bedogni, David Antoniucci, Francesco Maisano, Antonio Marzocchi, Arnaldo Poli, Marco De Carlo, Claudia Fiorina, Federico De Marco, Massimo Napodano, Roberto Violini, Alessandro Santo BortoneCorrado Tamburino

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Coronary artery disease (CAD) commonly coexists with degenerative aortic stenosis. The impact of CAD in patients undergoing transcatheter aortic valve implantation (TAVI) raises concerns due to the lack of comprehensive and consistent data on this topic. We sought to evaluate the impact of CAD on clinical outcomes in patients undergoing TAVI. Methods: Consecutive patients(N = 663) who underwent TAVI with the 18-French CoreValve ReValving System (CRS) (Medtronic Inc, MN USA) from June 2007 through December 2009 at 14 institutions across Italy were included in this prospective web-based registry. Four patients were excluded from the analysis due to failure to successfully release the prosthesis inside the native aortic valve. Previous percutaneous or surgical myocardial revascularizations were used to identify the existence of concomitant CAD (N = 251; 38%). The primary endpoint was the incidence of Major Adverse Cerebrovascular and Cardiac Events (MACCE) and all-cause death in CAD and no-CAD groups. Results: Patients with CAD were no more likely to develop MACCE within 12-months of the procedure than those who did not (CAD group vs no-CAD group, 15.7% vs 18.3%; adjusted hazard ratio [HR] 0.76; 95% confidence interval [CI] 0.42 to 1.36; p = 0.353). The 12-month mortality was 14.5% and 15.9% in CAD group and no-CAD group, respectively (adjusted HR 0.74; 95% CI 0.40 to 1.36; p = 0.331). Conclusions: Coexisting CAD does not impact procedural outcomes and mid-term incidence of MACCE and survival in elderly patients undergoing TAVI with CRS prosthesis.

Original languageEnglish
Pages (from-to)943-950
Number of pages8
JournalInternational Journal of Cardiology
Volume167
Issue number3
DOIs
Publication statusPublished - Aug 10 2013

Fingerprint

Registries
Coronary Artery Disease
Prostheses and Implants
Transcatheter Aortic Valve Replacement
Confidence Intervals
Myocardial Revascularization
Aortic Valve Stenosis
Incidence
Aortic Valve
Italy
Cause of Death
Survival
Mortality

Keywords

  • Aortic stenosis
  • Atherosclerosis
  • Coronary artery disease
  • TAVI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation : Insight from the Italian CoreValve Registry. / Ussia, Gian Paolo; Barbanti, Marco; Colombo, Antonio; Tarantini, Giuseppe; Petronio, Anna Sonia; Ettori, Federica; Ramondo, Angelo; Santoro, Gennaro; Klugmann, Silvio; Bedogni, Francesco; Antoniucci, David; Maisano, Francesco; Marzocchi, Antonio; Poli, Arnaldo; De Carlo, Marco; Fiorina, Claudia; De Marco, Federico; Napodano, Massimo; Violini, Roberto; Bortone, Alessandro Santo; Tamburino, Corrado.

In: International Journal of Cardiology, Vol. 167, No. 3, 10.08.2013, p. 943-950.

Research output: Contribution to journalArticle

Ussia, GP, Barbanti, M, Colombo, A, Tarantini, G, Petronio, AS, Ettori, F, Ramondo, A, Santoro, G, Klugmann, S, Bedogni, F, Antoniucci, D, Maisano, F, Marzocchi, A, Poli, A, De Carlo, M, Fiorina, C, De Marco, F, Napodano, M, Violini, R, Bortone, AS & Tamburino, C 2013, 'Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry', International Journal of Cardiology, vol. 167, no. 3, pp. 943-950. https://doi.org/10.1016/j.ijcard.2012.03.089
Ussia, Gian Paolo ; Barbanti, Marco ; Colombo, Antonio ; Tarantini, Giuseppe ; Petronio, Anna Sonia ; Ettori, Federica ; Ramondo, Angelo ; Santoro, Gennaro ; Klugmann, Silvio ; Bedogni, Francesco ; Antoniucci, David ; Maisano, Francesco ; Marzocchi, Antonio ; Poli, Arnaldo ; De Carlo, Marco ; Fiorina, Claudia ; De Marco, Federico ; Napodano, Massimo ; Violini, Roberto ; Bortone, Alessandro Santo ; Tamburino, Corrado. / Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation : Insight from the Italian CoreValve Registry. In: International Journal of Cardiology. 2013 ; Vol. 167, No. 3. pp. 943-950.
@article{11b9a5af7c1c4330abc53e8e546bbc07,
title = "Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry",
abstract = "Background: Coronary artery disease (CAD) commonly coexists with degenerative aortic stenosis. The impact of CAD in patients undergoing transcatheter aortic valve implantation (TAVI) raises concerns due to the lack of comprehensive and consistent data on this topic. We sought to evaluate the impact of CAD on clinical outcomes in patients undergoing TAVI. Methods: Consecutive patients(N = 663) who underwent TAVI with the 18-French CoreValve ReValving System (CRS) (Medtronic Inc, MN USA) from June 2007 through December 2009 at 14 institutions across Italy were included in this prospective web-based registry. Four patients were excluded from the analysis due to failure to successfully release the prosthesis inside the native aortic valve. Previous percutaneous or surgical myocardial revascularizations were used to identify the existence of concomitant CAD (N = 251; 38{\%}). The primary endpoint was the incidence of Major Adverse Cerebrovascular and Cardiac Events (MACCE) and all-cause death in CAD and no-CAD groups. Results: Patients with CAD were no more likely to develop MACCE within 12-months of the procedure than those who did not (CAD group vs no-CAD group, 15.7{\%} vs 18.3{\%}; adjusted hazard ratio [HR] 0.76; 95{\%} confidence interval [CI] 0.42 to 1.36; p = 0.353). The 12-month mortality was 14.5{\%} and 15.9{\%} in CAD group and no-CAD group, respectively (adjusted HR 0.74; 95{\%} CI 0.40 to 1.36; p = 0.331). Conclusions: Coexisting CAD does not impact procedural outcomes and mid-term incidence of MACCE and survival in elderly patients undergoing TAVI with CRS prosthesis.",
keywords = "Aortic stenosis, Atherosclerosis, Coronary artery disease, TAVI",
author = "Ussia, {Gian Paolo} and Marco Barbanti and Antonio Colombo and Giuseppe Tarantini and Petronio, {Anna Sonia} and Federica Ettori and Angelo Ramondo and Gennaro Santoro and Silvio Klugmann and Francesco Bedogni and David Antoniucci and Francesco Maisano and Antonio Marzocchi and Arnaldo Poli and {De Carlo}, Marco and Claudia Fiorina and {De Marco}, Federico and Massimo Napodano and Roberto Violini and Bortone, {Alessandro Santo} and Corrado Tamburino",
year = "2013",
month = "8",
day = "10",
doi = "10.1016/j.ijcard.2012.03.089",
language = "English",
volume = "167",
pages = "943--950",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation

T2 - Insight from the Italian CoreValve Registry

AU - Ussia, Gian Paolo

AU - Barbanti, Marco

AU - Colombo, Antonio

AU - Tarantini, Giuseppe

AU - Petronio, Anna Sonia

AU - Ettori, Federica

AU - Ramondo, Angelo

AU - Santoro, Gennaro

AU - Klugmann, Silvio

AU - Bedogni, Francesco

AU - Antoniucci, David

AU - Maisano, Francesco

AU - Marzocchi, Antonio

AU - Poli, Arnaldo

AU - De Carlo, Marco

AU - Fiorina, Claudia

AU - De Marco, Federico

AU - Napodano, Massimo

AU - Violini, Roberto

AU - Bortone, Alessandro Santo

AU - Tamburino, Corrado

PY - 2013/8/10

Y1 - 2013/8/10

N2 - Background: Coronary artery disease (CAD) commonly coexists with degenerative aortic stenosis. The impact of CAD in patients undergoing transcatheter aortic valve implantation (TAVI) raises concerns due to the lack of comprehensive and consistent data on this topic. We sought to evaluate the impact of CAD on clinical outcomes in patients undergoing TAVI. Methods: Consecutive patients(N = 663) who underwent TAVI with the 18-French CoreValve ReValving System (CRS) (Medtronic Inc, MN USA) from June 2007 through December 2009 at 14 institutions across Italy were included in this prospective web-based registry. Four patients were excluded from the analysis due to failure to successfully release the prosthesis inside the native aortic valve. Previous percutaneous or surgical myocardial revascularizations were used to identify the existence of concomitant CAD (N = 251; 38%). The primary endpoint was the incidence of Major Adverse Cerebrovascular and Cardiac Events (MACCE) and all-cause death in CAD and no-CAD groups. Results: Patients with CAD were no more likely to develop MACCE within 12-months of the procedure than those who did not (CAD group vs no-CAD group, 15.7% vs 18.3%; adjusted hazard ratio [HR] 0.76; 95% confidence interval [CI] 0.42 to 1.36; p = 0.353). The 12-month mortality was 14.5% and 15.9% in CAD group and no-CAD group, respectively (adjusted HR 0.74; 95% CI 0.40 to 1.36; p = 0.331). Conclusions: Coexisting CAD does not impact procedural outcomes and mid-term incidence of MACCE and survival in elderly patients undergoing TAVI with CRS prosthesis.

AB - Background: Coronary artery disease (CAD) commonly coexists with degenerative aortic stenosis. The impact of CAD in patients undergoing transcatheter aortic valve implantation (TAVI) raises concerns due to the lack of comprehensive and consistent data on this topic. We sought to evaluate the impact of CAD on clinical outcomes in patients undergoing TAVI. Methods: Consecutive patients(N = 663) who underwent TAVI with the 18-French CoreValve ReValving System (CRS) (Medtronic Inc, MN USA) from June 2007 through December 2009 at 14 institutions across Italy were included in this prospective web-based registry. Four patients were excluded from the analysis due to failure to successfully release the prosthesis inside the native aortic valve. Previous percutaneous or surgical myocardial revascularizations were used to identify the existence of concomitant CAD (N = 251; 38%). The primary endpoint was the incidence of Major Adverse Cerebrovascular and Cardiac Events (MACCE) and all-cause death in CAD and no-CAD groups. Results: Patients with CAD were no more likely to develop MACCE within 12-months of the procedure than those who did not (CAD group vs no-CAD group, 15.7% vs 18.3%; adjusted hazard ratio [HR] 0.76; 95% confidence interval [CI] 0.42 to 1.36; p = 0.353). The 12-month mortality was 14.5% and 15.9% in CAD group and no-CAD group, respectively (adjusted HR 0.74; 95% CI 0.40 to 1.36; p = 0.331). Conclusions: Coexisting CAD does not impact procedural outcomes and mid-term incidence of MACCE and survival in elderly patients undergoing TAVI with CRS prosthesis.

KW - Aortic stenosis

KW - Atherosclerosis

KW - Coronary artery disease

KW - TAVI

UR - http://www.scopus.com/inward/record.url?scp=84880920686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880920686&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2012.03.089

DO - 10.1016/j.ijcard.2012.03.089

M3 - Article

C2 - 22459391

AN - SCOPUS:84880920686

VL - 167

SP - 943

EP - 950

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -